Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05038462
NA

Fetal Brain Care: Therapies for Brain Neurodevelopment in Fetal Growth Restriction

Sponsor: Institut d'Investigacions Biomèdiques August Pi i Sunyer

View on ClinicalTrials.gov

Summary

Singleton pregnancies being diagnosed of fetal growth restriction from 24 to 32.6 weeks of gestation will be randomized to two equally sized groups: maternal oral supplementation with Lactoferrin and DHA (Docosahexaenoic acid) or placebo.

Key Details

Gender

FEMALE

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

304

Start Date

2023-01-18

Completion Date

2026-12

Last Updated

2024-03-18

Healthy Volunteers

No

Interventions

DIETARY_SUPPLEMENT

Lactoferrin and DHA

The intervention consists in the maternal oral administration of 1000mg of Lactoferrin and 1000mg of DHA daily

OTHER

Placebo

Product with the same physical appearance and taste as the main intervention but without therapeutic effect

Locations (6)

Hospital Clínic de Barcelona

Barcelona, Spain

Hospital de la Santa Creu i Sant Pau

Barcelona, Spain

Hospital del Mar

Barcelona, Spain

Hospital Dexeus-Quirón

Barcelona, Spain

Hospital Sant Joan de Déu

Esplugues de Llobregat, Spain

Hospital General del Hospitalet

L'Hospitalet de Llobregat, Spain